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1. Introduction 
One of the most common models used in pre-clinical studies is nude mice implanted with 
brain tumors. In fact, owing to a deficiency in their immune systems, nude mice allow 
many tumor models to be studied and a wide range of therapeutic treatments to be 
investigated. 
The best way to evaluate the efficiency of a treatment is to compare the kinetics of the tumor 
volume between a control group and a treatment group [1-3]. Since brain tumors generally 
evolve very quickly (7 to 15 days) in mice, the tumor must be detected early and 
characterized daily.  
The advantages of non-invasive imaging methods are evident compared with conventional 
methods such as histochemistry, where animal sacrifice, end-point analysis only, and 2D 
tumor-diameter measurement are mandatory. 
However, obtaining images of high spatial resolution and high contrast for the same animal 
in a longitudinal study is not trivial. 
As in clinical MR imaging, the tumor can be detected in two possible ways. The first consists 
of using a gadolinium-based contrast agent injected intravenously to visualize the 
breakdown of the blood–brain barrier. Using a T1-weighted 3D gradient-echo sequence, 
high-resolution images can be obtained in a reasonable acquisition time. Nevertheless, 
because of the injuries caused by repeated injection of contrast agent into the tail vein, 
experiments cannot be performed frequently [1]. The other way consists of using T2-
weighted sequences. RARE imaging, with or without magnetization transfer preparation [3–
5], allows small tumors to be detected noninvasively. The sequence is usually acquired in 
multi-slice 2D imaging in order to limit the total acquisition time. However, high-resolution, 
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accurate 3D information is very important in longitudinal studies such as, for instance, the 
evaluation of a therapeutic treatment. 
An alternative to RARE T2 [6] or 3D contrast-enhanced T1 imaging is fully balanced SSFP 
imaging (also called bSSFP, TrueFISP or FIESTA) [7]. In fact, it has recently been shown that 
this sequence can be used at high field, in 3D, to detect tumors of very small size [8]. The 
advantage of this sequence is the ability to combine the speed of 3D gradient echo and 
T1/T2 contrast. 
The purpose of this study is to demonstrate that a 3D TrueFISP MRI sequence is applicable, 
at high magnetic field, to glioma-bearing mouse models in longitudinal studies. Theoretical 
considerations of tumor contrast and signal-to-noise ratio as a function of sequence 
parameters (TE/TR/flip angle) were carried out and compared with experimental data. 
The 3D TrueFISP MRI sequence was also compared with the sequence most widely used in 
clinical applications: 2D RARE. Finally, the sequence was used to perform accurate 
longitudinal measurements of glioma volumes in mice. 
2. Materials and methods 
2.1 MRI system 
Magnet 
NMR machines to image small animals are becoming more and more widespread. The 
various manufacturers have developed systems for use in studies using small animals by 
adapting their components (magnet, gradients, antennae, monitoring system and animal 
handling solutions).  
The main component of an MRI system is the magnet, which generates an intense static 
magnetic field. While for clinical imaging 1.5-T and 3-T magnets are used, for rats and 
mice a magnetic field between 4.7 T and 11.6 T is generally used. The magnets can be 
positioned either horizontally or vertically. This type of magnetic fields provides an 
increased signal-to-noise ratio (S/N), required for the acquisition of highly spatially 
resolved images. However, a theoretical increase in signal causes problems which must be 
considered when high-quality images are to be obtained. In this way, an increase in 
magnetic field leads to a reduced natural contrast between the tissues in T2 or T1-
weighted scans. In addition, susceptibility effects are enhanced and may lead to artifacts 
with gradient-echo sequences.  
Most of the images presented here were acquired at 4.7 T. This level of magnetic field 
provides a compromise between signal-to-noise ratio, contrast and sensitivity to 
susceptibility artifacts. The use of a more intense magnetic field will also be addressed. 
2.2 Gradient system 
The second essential component of an MRI system is the magnetic field gradient. Gradients 
allow the image to be spatially encoded. When imaging small animals, the spatial resolution 
required is much greater than for human imaging. For example, in anatomic imaging of rats, 
a voxel size of at least 400 µm is required in all three dimensions (3D); in mice, a size of at 
least 200 µm is needed.  
In MRI, the digital resolution, i.e. pixel size, is inversely proportional to the gradient 
intensity, G, and application time, tG (Eq. [1]). 
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(1)
 
The actual resolution is inversely proportional to the relaxation time, T2*, and to the 
gradient intensity and application time (Eq. [2]).  
  
(2)
 
The advantages of using intense magnetic field gradients are thus obvious, particularly at 
strong magnetic fields, with very short T2*. 
Commercial gradient systems have been developed with intensities of greater than 
400 mT/m over 10 cm, up to 1 T/m over 3 cm. Because the target diameter of these gradient 
systems is spatially limited, they can only be used to study animals such as rats or mice. 
 
 
Fig. 1. Photograph of a 1-T/m gradient system. The system can be inserted into a magnet 
equipped with a 12-cm-diameter tunnel and can contain an antenna up to 6 cm in diameter. 
The gradient is linear over a distance of approximately 3 cm. 
2.3 Coil 
Image quality is also significantly affected by the choice of antenna. The S/N depends 
entirely on this component as it is proportional to the square root of the antenna's quality 
factor, Q. Thus, a well-designed antenna is recommended. In addition, the S/N is directly 
proportional to the filling factor for the antenna, represented by η in Eq. [3]. 
  
(3)
 
Optimal image quality will therefore be obtained using an antenna with a size and shape 
perfectly adapted to the zone to be imaged. Several types of antennae have been developed 
and can be used to meet these criteria. Volumetric emission/reception antennae are the most 
common. They provide a very homogeneous radio-frequency field, often required when 
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using spin-echo sequences. However, their filling factor is relatively low, which can penalize 
the S/N. This sensitivity problem can be partially mitigated by using cross-polarized 
antennae. This type of volumetric antenna is the easiest to use, and was used for the images 
presented in this chapter. 
Surface antennae can also be used, offering an excellent quality factor combined with a very 
high filling factor. This type of antenna therefore provides a higher S/N than the antennae 
described previously. 
However, due to their configuration, the flip angle applied varies depending on the depth of 
the zone to be imaged within the sample, making the use of spin-echo sequences impossible. 
In addition, with this type of antenna, contrast can vary depending on the depth of the zone 
observed within the sample. 
Finally, in clinical imaging, and increasingly for small-animal imaging, volumetric emission 
antennae coupled to an array of surface reception antennae are the most commonly used. 
This setup offers the advantages of the two types of antennae described above: excellent B1 
emission homogeneity associated with an excellent signal-to-noise ratio. 
 
 
Fig. 2. a) Cross-polarized 25-mm-diameter volumetric antenna; b) 16-mm-diameter surface 
emission/reception antenna; c) & d) antenna system combining volumetric emission (80 mm 
in diameter) and phased-array reception. 
These three types of antennae are exclusively used for mouse brain imaging and were tuned 
to 200 MHz in the experiments described here. 
2.4 Animal handling/monitoring 
Finally, quality imaging in small animals requires a specific component to position and 
monitor the animal. This component must allow the animal to be maintained in a stable and 
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fairly reproducible position. In particular, it must allow imaging to be applied repeatedly 
(approximately once a day) to particularly fragile animals. 
A tooth bar assembly is generally used to position the animal's head based on the position of 
its teeth. Ear bars may be added but are not always necessary. This type of stereotactic 
positioning is often used for brain imaging in animals. 
The animal is monitored by measuring its respiratory rate using an air balloon placed on the 
abdomen or back of the animal and connected to a pressure sensor linked to a computer via 
an optical fiber during imaging sessions. The respiratory rate can thus be followed on a 
computer screen in real time. 
Isoflurane inhalation-based anesthesia is used, with adaptation of the percentage of 
isoflurane mixed with air to maintain the animal’s respiration rate at greater than 70 and less 
than 110 breaths/min. Isoflurane can be recycled through a capture system. 
The animal’s body temperature is maintained constant either with an electric blanket, or by 
using circulating hot water to maintain the gradient system at 32 °C. 
 
 
Fig. 3. Nude mouse in a home-made bed. A tooth-bar assembly holds the animal in position 
and a 1-2% air/isoflurane mixture is delivered in the region of the nose. A balloon is placed 
on the animal’s back to measure its respiration rate. The SA Instruments system is linked to 
a computer, where the animal's respiration can be visualized on-screen. 
2.5 Animal model 
U87 human brain tumor cells were implanted in nude mice (18-20 g, n = 20, Charles Rivers, 
L’Arbresle, France) by stereotactic injection into the striatum. Mice were anesthetized with 
isoflurane (1.5% in air) and secured in the stereotactic apparatus (Stoelting Europe, Dublin, 
Ireland). The scalp was cleaned with Betadine (MEDA Pharma, Paris, France) and the skull 
was exposed by midline scalp excision. A small hole (0.5 mm in diameter) was then drilled 
0.1 mm posterior and 2.3 mm left to the bregma. Five hundred thousand U87 cells dissolved 
in 2 mL of Minimum Essential Medium were injected using a 10-mL Hamilton syringe into 
the left hemisphere at a depth of 3 mm below the brain's surface. On withdrawal of the 
injection needle, the hole in the skull was sealed with bone wax and the scalp was sutured. 
www.intechopen.com
 
Advances in the Biology, Imaging and Therapies for Glioblastoma 
 
130 
3. Sequence 
3.1 RARE 2D 
T2-weighted sequences are the most widely used for imaging-based tumor detection. These 
are accelerated spin-echo sequences (RARE, or Rapid Acquisition with Refocused Echoes) 
which are generally acquired in two dimensions (2D), in multi-slice mode. When these 
sequences are used for clinical imaging, pulses are often added to suppress fluid signals 
(FLAIR, or Fluid-Attenuated Inversion Recovery). 
To image small animals, the following parameters are used: 
in 2D 
TE/TR = 70/5,000 ms; FOV: 22.5 x 22.5 mm; matrix: 192 x 128; spatial resolution: 
117 x 175 µm; slice thickness: 750 µm; excitation pulse: Hermite 1 ms, 90°; refocusing pulse: 
Hermite 1 ms, 180°; reception bandwidth: 260 Hertz/pixel; RARE factor: 32; number of 
averages: 32, total acquisition time: 10 min 40 sec; transverse orientation. 
3.2 TrueFISP 
The specificity of bSSFP (balanced Steady-State Free Precession) type sequences, also known 
as TrueFISP or FIESTA, is their perfect symmetry, with an echo time (TE) equal to half the 
repetition time (TR). This maintains the magnetization in the transverse plane. Due to spin 
dephasing, the signal generated is more intense than with gradient-echo sequences. This 
allows 3D images to be constructed with good spatial resolution within a reasonable 
acquisition time. Besides, the tissue contrast generated is proportional to the T1/T2 ratio. 
The alternating phase RF pulse method must be used with 4 or 8 Δφ phase values (180°, 0°, 
90°, 270°; 45°, 135°, 225°, 315°). Image reconstruction is based on the Sum-Of-Square (SOS) 
method, i.e. calculation of the square root of the sum of squares of the magnitude signal. 
 
 
Fig. 4. 3D TrueFISP sequence chronogram. The RF pulse phase indicated generates images 
corresponding to the following Δφ values: 180°, 0°, 90°, 270°. The sequence is perfectly 
symmetrical about the center of the echo. Thus, the echo time (TE) is equal to half the 
repetition time (TR). 
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The following sequence parameters are used:  
- TE/TR = 2.5/5 ms; FOV: 32 x 18 x 18 mm; matrix: 192 x 96 x 80; spatial resolution: 
166 x 187 x 225 µm; excitation pulse: Hermite 0.4 ms; reception bandwidth: 
260 Hertz/pixel; number of averages (NA): 16 (including 4 Δφ values), total acquisition 
time: 2 min 34 sec x4 = 10 min 16 sec; transverse orientation. 
- TE/TR = 1.5/3 ms;  
- TE/TR = 5/10 ms;  
- TE/TR = 10/20 ms;  
3.3 Theory 
Simulations of the state of magnetization with TrueFISP, gradient-echo and spin-echo 
sequences were performed in Igor Pro using well-known equations (Eq. [4], [5] and [6)]. 
They were performed as a function of flip angle α, TR, TE or the T1 and T2 values of tissues. 
At 4.7 T, the T1 and T2 values of brain was equal to 1,295 ms and 53 ms, respectively, and 
for tumors, 1,525 and 72 ms, respectively [8].  
- TrueFISP  
  
(4) 
   
- Gradient echo 
   
(5) 
with TE = 2.5 ms and T2* = 25 ms 
- Spin echo  
A 1/6.32 correction factor was applied to 2D RARE (Eq. [6]), corresponding to the voxel size, 
the number of averages and the number of k-space samples by comparison with 3D 
TrueFISP acquisition. 
  
(6)
 
S/N was simulated for the brain and tumor, and contrast was evaluated according to 
Eq. [7]. 
  (7) 
The signal-to-noise ratio was evaluated for both tumor and brain tissues. For the TrueFISP 
sequence, the maximal signal was obtained with the shortest possible TE and a flip angle 
between approximately 15° and 35°, as shown in Figs. 5ab. The slight S/N difference 
between the healthy brain and the tumor is also observable. The gradient-echo sequence 
generates a much lower S/N compared with the TrueFISP sequence for all flip angles. 
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Fig. 5. Modeling of the signal-to-noise ratio using the above equations for: ab) the TrueFISP 
sequence, c) the gradient-echo sequence, and d) the spin-echo sequence. The signal was 
estimated as a function of the flip angle and TR for a), b), and c). For the spin-echo sequence, 
the signal was estimated as a function of the TEs and TRs of the sequence. The T1 and T2 
values for the brain (1,295 ms and 53 ms, respectively) were used in a), c), and d). The T1 
and T2 values for the tumor (1,525 ms and 72 ms, respectively) were used in b). The same 
color scale was used in the 4 simulations. To allow for the 2-dimensional nature of the spin-
echo sequence, a correction factor was applied. 
The spin-echo sequence should provide a high S/N, provided the TR is long and TE very 
short. However, these acquisition conditions do not provide sufficient contrast, as shown in 
the following figure.  
We can thus clearly see the advantage of the TrueFISP sequence, as far as the S/N is 
concerned, for an equivalent total acquisition time, compared with both a standard 3D 
gradient-echo sequence and a 2D RARE spin-echo sequence. 
3.4 Contrast 
The contrast was then assessed theoretically, based on the signal difference between the 
tumor and the healthy brain. For the TrueFISP sequence (Fig. 6a), optimal contrast was 
achieved with a short TE and a flip angle between 25° and 50°.  
The gradient-echo sequence provided almost no contrast compared with the TrueFISP 
sequence, while the spin-echo sequence provided improved contrast for TRs over 3,500 ms 
and TEs greater than 50 ms.  
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To conclude on these simulations (S/N and contrast), a very high S/N can be expected with 
the TrueFISP sequence. This method provides adequate contrast between the brain and 
tumor with flip angles around 30° and short TEs. Yet, contrast should be improved with the 
T2-weighted accelerated spin-echo sequence (RARE), but this method is generally used to 
acquire 2D images only, thus limiting its capacity to measure tumor volumes. Using it for 
3D imaging can produce artifacts due to movements, and the acquisition time is much 
longer than with the TrueFISP sequence.  
 
 
Fig. 6. Simulation of the contrast between tumor and brain using a) the 3D TrueFISP 
sequence, b) the 3D gradient-echo sequence, and c) the 2D spin-echo sequence. The contrast 
is estimated as a function of the flip angle and TR for the TrueFISP and gradient-echo 
sequences, and as a function of TE and TR for the spin-echo sequence. 
4. Results 
4.1 Correction of TrueFISP banding artifacts 
TrueFISP images were acquired at 4.7 T using a cross-polarized antenna. A U87 glioma was 
implanted in a mouse, and imaging was performed 4 days later.  
Fig. 7.a shows the image acquired using the TrueFISP sequence with a TE of 2.5 ms, a flip 
angle of 35°, and a Δφ value of 180°. As expected, black-signal bands are clearly visible in 
the image. These hinder visualization of parts of the animal’s brain. Modifying the Δφ value 
(to 0°, 90°, and 270°) shifts the positions of the null-signal bands. For some of these values 
(Δφ = 270°), the tumor is clearly visible, while for others (Δφ = 90°), the null-signal zone 
covers the area containing the tumor, making all subsequent analyses of the tumor 
impossible. 
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Fig. 7. Brain images from a mouse with an implanted tumor on day 4 after implantation. 
Images were obtained using the 3D TrueFISP sequence at 4.7 T and Δφ = 180° (a), 0° (b), 90° 
(c), 270° (d). Null-signal bands are clearly visible and shift in position. Image e was obtained 
by SOS reconstruction from a) and b). The arrow indicates a non-compensated low-signal-
intensity band. Image f was obtained by reconstruction from a), b), and c). The arrow 
indicates a high-signal-intensity band. Finally, Image g was obtained from the 4 images a), 
b), c), and d). The arrow shows the tumor, with a volume of less than 2 µL. 
To eliminate these null-signal bands, the images acquired in a), b), c), and d) can be 
combined. To do so, various methods have been described in the literature, such as the sum 
of k-spaces, the sum of magnitude images, or the square root of the sum of squares of 
magnitude images. The latter method will be used here as it has been shown to be the most 
effective [14]. 
As shown in Images a-b, the black-signal bands do not appear to overlap. These two images 
were therefore combined to produce Image e. This eliminated the very pronounced null-
signal bands, and the tumor became clearly visible. Nevertheless, the signal was not 
homogeneous throughout the brain, and a band (indicated by the white arrow in Image e) 
shows a reduced signal intensity compared with other areas of the brain. This type of 
artifact appears in various positions for all types of combinations of 2 images (ac, ad, bc, 
etc.). 
This low-signal-intensity band could be eliminated by adding a third image to the 
combination (a, b, and c). However, a band of slightly higher signal intensity (white arrow 
in Image f) appeared. The position of this band corresponds to the black-signal band in 
Image d.  
Finally, by adding Image d to the final combination, Image g was obtained (g = (a2 + b2 + c2 
+ d2)1/2. In this case, the brain appears perfectly homogeneous and the tumor is clearly 
visible. 
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4.2 Influence of flip angle on S/N and contrast on TrueFISP imaging 
As shown in the simulations, for a TR of 5 ms, the S/N should be optimal with a flip angle 
between 15° and 35°. On the other hand, contrast between tumor and brain should be 
optimal with a flip angle between 25° and 55°. For a fixed TE, TrueFISP images were 
acquired with a flip angle between 8° and 35°. Above this range, the S/N is reduced and, 
more importantly, signals from sub-cutaneous fat and fluids (such as cerebrospinal fluid) 
become very intense. This leads to a strong reduction in signal dynamics for the brain and 
tumor, and generates images which are more difficult to interpret. 
 
 
 
Fig. 8. Images obtained using the 3D TrueFISP sequence after correction of banding artifacts 
according to the α flip angle. TE was set to 2.5 ms. 
The best contrast between brain and tumor was achieved at 35°. For α = 25 and 30°, good 
contrast was maintained, providing easy tumor detection, and the S/N was increased. 
Below this, the signal for healthy brain was increased and the tumor became difficult to 
distinguish. An 8° angle gave rise to more TrueFISP artifacts in different positions. At this 
value, reconstruction could not generate an image without null-signal bands, and the tumor 
became indistinguishable from the surrounding brain. 
The table below gives the S/N and contrast between the brain and tumor for the various flip 
angles. To summarize, flip angles between 25 and 35° allow tumors to be segmented semi-
automatically based on tissue contrast. 
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Table 1. S/N and contrast for brain and tumor, as a function of the flip angle, α. TE was set 
to 2.5 ms. 
4.3 Influence of TE on S/N and contrast in TrueFISP imaging 
Using a low bandwidth generates images with a high S/N. However, a decrease in 
bandwidth causes an increase in the sequence's TE. The influence of this was measured over 
the range between 1.5 and 10 ms (with the flip angle set at 35°). With a low TE (1.5 ms), the 
contrast appeared better than in the reference image acquired at 2.5 ms, but the S/N was 
significantly reduced, and the signal from fatty tissue was increased due to its relatively low 
T1. This resulted in a lower-quality image. Interestingly, at higher TEs (5 and 10 ms), the 
TrueFISP sequence generated few susceptibility artifacts compared with a FLASH sequence 
with the same TE (data not shown). However, at TE = 10 ms, the tumor was no longer 
visible due to a strongly reduced contrast between brain and tumor. 
As described in the table below, only a TE value of 2.5 ms provides a contrast greater than 
10, allowing the tumor to be segmented semi-automatically. 
 
 
Fig. 9. Images acquired using the 3D TrueFISP sequence after correction of banding artifacts 
based on TE. The flip angle was set to 35°. 
 
 
Table 2. S/N and contrast for brain and tumor, as a function of the echo time. The flip 
angle α was set at 35°. 
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4.4 Comparison between RARE and TrueFISP imaging 
The reference method for tumor detection by anatomic imaging is T2-weighted spin-echo 
imaging. Images were therefore acquired with a T2-weighted 2D RARE sequence. This 
sequence detects the tumor despite its small size (see Fig. 10d). In addition, as expected from 
simulations, contrast between the tumor and healthy brain is higher than with the TrueFISP 
sequence (Fig. 10a). The total acquisition time for the 2D RARE sequence was comparable with 
that for the 3D TrueFISP sequence. However, as the images were acquired in 2D by multi-slice 
imaging, reconstruction in other dimensions generates images with poor resolution and low 
quality (Figs. 10ef) compared with the 3D TrueFISP sequence (Figs. 10bc).  
The two imaging methods were next used to measure tumor volume. With the TrueFISP 
sequence, the volume was estimated at 2.4 µL, while with the RARE sequence it was 
estimated at 4.3 µL. This overestimation of the volume with the RARE sequence is due to the 
low spatial resolution of this sequence in the third dimension. Actually, significant partial-
volume effects are generated by this sequence and lead to volume-measurement errors.  
A 3D RARE sequence validated the 2.4 µL volume determined using the TrueFISP sequence. 
The 3D RARE image was acquired over 45 minutes. 
 
 
Fig. 10. 3D TrueFISP (a, b, and c) and multi-slice 2D RARE imaging (d, e, and f) of a mouse 
with implanted glioma: a) & d) sagittal sections; b) & e) reconstruction of transverse 
sections; c) & f) reconstruction of coronal sections. The white arrows indicate the tumor. 
Volume overestimation based on 2D imaging was confirmed by using the two sequences to 
image a phantom consisting of a known volume of water. With the 2D RARE sequence, the 
error in volume measurement was around 20%, while with the TrueFISP sequence the error 
was only 4%. 
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4.5 Imaging at 9.4T 
Images were acquired with the same 2 sequences at 9.4 T on a mouse model of glioma. To 
suppress banding artifacts with the TrueFISP sequence, 8 images had to be acquired with 
8 different Δφ values (180°, 0°, 90°, 270°, 45°, 135°, 225°, 315°). 
 
 
Fig. 11. 2D RARE (a) and 3D TrueFISP (b) imaging at 9.4 T. With RARE imaging, the tumor 
is clearly visible, while TrueFISP provides a lower tumor/brain contrast. 
With the RARE sequence, the tumor is clearly detectable and contrast is comparable with 
that of an image acquired at 4.7 T (Fig. 10a). For the TrueFISP sequence, the contrast is 
reduced, making it very difficult to distinguish the tumor from the remainder of the brain, 
except from the presence of structural heterogeneity. In this case, it is not possible to semi-
automatically segment the tumor, and it is therefore impossible to measure its volume with 
good reproducibility. In addition, as demonstrated previously, small tumors may turn out 
to be undetectable. 
 
 
Table 3. S/N and contrast for brain and tumor, at 4.7 T and 9.4 T, with RARE and TrueFISP 
sequences. 
4.6 Longitudinal follow up of glioma volume at 4.7T 
The simulations and experiments performed above show that an implanted tumor can be 
unambiguously distinguished by 3D TrueFISP imaging when a TE of 2.5 ms is combined 
with a flip angle of 35° for imaging at 4.7 T. These parameters were therefore used for the 
longitudinal follow-up of tumor volume in an animal implanted with a U87-type glioma. 
Images were also acquired with the 2D RARE sequence to compare volume 
measurements.  
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The tumor was easily detectable 7 days after implantation despite its small volume (2 µL). 
The images obtained with the TrueFISP sequence are shown from day 9 after implantation. 
The animal was then followed up for approximately 30 days, with a 2 or 3-day interval 
between MRI scans. The increase in tumor diameter is visible in the images (Fig. 12). From 
d25, zones of black signal appear in the tumor's center, these are probably due to necrotic 
areas.  
 
 
Fig. 12. Longitudinal follow-up of tumor progression by 3D TrueFISP imaging at 4.7 T. 
Images ab show the sagittal and transverse sections of the mouse brain at d9 after 
implantation. Images cj show tumor progression between d11 and d28. 
Based on these 3D images (a-h), the tumor can readily be semi-automatically segmented, 
and the 3D volume could be reconstructed (Fig. 13). In Images i-j, the tumor/brain contrast 
is lower, but the tumor can still be manually delimited and its volume measured.  
Based on these 3D reconstructions, tumor volume progression was reported as a function of 
time (Fig. 14). Tumor growth could thus be assessed, from its initial approximately 4µL 
volume up to its final 100µL volume, i.e. approximately one quarter of the animal's total 
brain volume. 
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On the other hand, with the 2D RARE sequence, the tumor is also visible from day 7 after 
implantation. However, the volume measured based on images acquired with the RARE 
sequence is always greater than that measured by TrueFISP, and, importantly, very little 
difference is observed over the first 4 analysis times (d9, d11, d14, d16). This is probably due 
to a less precise measurement of the tumor volume, which, as indicated above, is due to 
very low spatial resolution in the third dimension. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13. 3D reconstruction of the tumor by semi-automatic segmentation from the images 
shown in Figure 11. Image a: reconstruction of the whole brain (gray) and the tumor (red) at 
d9. Images bj: 3D representation of the tumor over time. The same arbitrary scale is used in 
all images. 
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Fig. 14. Progression of tumor volume over time based on the volumes shown in Figure 13. 
5. Discussion and conclusion 
The aim of this chapter was to show how the 3D TrueFISP sequence can improve 
longitudinal follow-up of glioma volume in a given animal model.  
This sequence is rarely used at high magnetic fields as it generates numerous artifacts 
known as banding artifacts [10-12]. However, the S/N and contrast provided by this 
sequence can be useful in imaging small animals at high fields.  
It has been shown that these artifacts can be easily corrected at 4.7 T and 9.4 T when 
studying mouse brains, and also for areas which are much more sensitive to movements and 
susceptibility artifacts, such as the heart [8,13]. To do so, the so-called ‘alternating-phase RF 
pulse’ method is used, in combination with reconstruction through calculation of the square 
root of the sum of squares of the magnitude signal [14]. As shown here, 4 phase steps are 
necessary to suppress artifacts at 4.7 T, while at least 8 steps are required at 9.4 T [8]. The 
resulting image appears perfectly homogeneous in terms of signal, and no longer displays 
artifacts. The requirement for 4 images increases the total acquisition time, but this 
nevertheless remains much shorter than with a T2-weighted 3D RARE sequence (12 min vs. 
45 min) [8,15]. 
The 3D TrueFISP imaging sequence was compared, in terms of S/N and contrast, with the 
more commonly used gradient-echo and spin-echo sequences. Simulations, which were 
confirmed by experimental results, indicate a clear superiority of this sequence in terms of 
S/N. As the sequence can be used with short TRs (like a gradient-echo sequence), it is 
perfectly adapted to 3D imaging, unlike spin-echo sequences which require long TRs. A 
high S/N is obtained with the magnetization maintained in the transverse plane, thanks to a 
zero gradient sum at the end of each TR. This is much better than ‘spoiling’, which is used 
with the more common gradient-echo or FLASH sequences. 
The TrueFISP sequence provides a much higher signal-to-noise ratio than a 2D accelerated 
spin-echo sequence. This is associated with better spatial resolution in the third dimension. 
Yet, the RARE sequence can also be used in 3D and also provides very high S/Ns. However, 
additional spatial encoding for the T2-weighted RARE spin echo has a drastic effect on the 
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total acquisition time: good T2 weighting is required for tumor detection, and can only be 
obtained with TRs greater than 3,500 ms. This leads to a total acquisition time on the order 
of 1 hour, whereas around 10 minutes is adequate with the 2D sequence or the 3D TrueFISP 
sequence. 
The TrueFISP sequence provides adequate contrast, allowing even very small tumors to be 
detected clearly, and semi-automatically segmented using generic image-analysis tools. 
However, as shown in both simulations and images, the contrast between the healthy brain 
and the tumor remains lower than that provided by the spin-echo sequence. This is due to 
TrueFISP-sequence weighting, which relies on the T1/T2 ratio, while the RARE sequence 
only uses T2 weighting. This has several consequences. In some cases, e.g. when the tumor 
becomes very large and heterogeneous, semi-automatic segmentation becomes difficult due 
to inadequate contrast with the healthy brain. Manual segmentation therefore becomes 
necessary, which may be both tedious and subjective. Nevertheless, the error rate when 
estimating even large volumes remains low.  
Another consequence is that it is almost impossible to detect a glioma in the brain at fields 
higher than 4.7 T based on natural contrast. This is because the T1 and T2 values for the 
brain and tumor become almost identical, which limits the contrast at very high magnetic 
fields. The T2-weighted RARE sequence still works perfectly at these higher fields.  
Thus, for this type of application, the TrueFISP sequence at 9.4 T or greater provides little 
advantage over other, more commonly used sequences. However, at low fields, the S/N and 
contrast provided by the TrueFISP sequence make it particularly interesting. It has already 
been shown with specific instruments that it allows tumors to be easily detected in mice 
based on natural contrast, and that it provides an excellent signal-to-noise ratio at clinical 
magnetic fields (1.5 T and 3 T) [16,17].  
In terms of spatial resolution, the advantages of 3D compared with 2D imaging are obvious. 
Three-dimensional imaging results in much smaller voxel sizes with comparable acquisition 
times, while maintaining a high S/N. This requires the addition of a phase-encoding table in 
the slice direction, i.e. a much greater number of lines read in the Fourier volume. The 
advantages of sequences with short TRs thus become obvious. As shown, the TrueFISP 
sequence also provides a much greater precision when measuring tumor volume, in 
particular for small tumors. With the 2D RARE sequence, it is impossible to precisely 
measure volume changes in the first days following tumor implantation. With the 3D 
TrueFISP sequence, this information is readily available.  
In addition, as the sequence is relatively rapid in terms of total acquisition time, it can be 
repeated at very short intervals to follow tumor progression, even in relatively fragile mice. 
The total examination, between preparation of the animal and imaging, lasts less than 
20 minutes. This makes it possible to study animals on a daily basis. This is much more 
difficult when contrast agents must be injected, or with acquisition times of around 1 hour, 
as with 3D RARE sequences [15]. 
To conclude, the 3D TrueFISP sequence can be easily used to follow tumor progression in a 
small animal model imaged at 4.7 T. Thanks to a particularly high S/N, artifact-free images 
can be acquired, with excellent spatial resolution and good tumor/healthy brain contrast. 
The total acquisition time remains under 15 minutes, thus offering precise longitudinal 
follow-up of tumor volume. Thus, this sequence could be used to noninvasively validate the 
efficacy of new genetic or pharmacological treatments for glioma. 
At lower magnetic fields, the sequence has also demonstrated its efficacy. In contrast, it is 
currently not applicable at 9.4 T or higher to precisely measure tumor volumes. 
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